Guidance

Asthma long-acting 脽2 agonists: use and safety

Uses of long-acting 脽2 agonists and current safety advice.

From:
Medicines and Healthcare products Regulatory Agency
Published
18 December 2014

Documents

Asthma Long-acting 脽2 agonists: use and safety

HTML

Details

This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance for healthcare professionals covers:

  • treatment
  • safety
  • available medicines
  • advice for use in children

Updates to this page

Published 18 December 2014

Sign up for emails or print this page

Related content